| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
|
Zureik, Mahmoud
|
|
|
78 |
5 |
p. 553-557
|
artikel
|
| 2 |
COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance
|
Massy, Nathalie
|
|
|
78 |
5 |
p. 489-498
|
artikel
|
| 3 |
Drugs and the elderly: A complex interaction
|
Bégaud, Bernard
|
|
|
78 |
5 |
p. 559-563
|
artikel
|
| 4 |
Editorial board
|
|
|
|
78 |
5 |
p. i
|
artikel
|
| 5 |
French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
|
de Canecaude, Claire
|
|
|
78 |
5 |
p. 517-522
|
artikel
|
| 6 |
Impact of coronavirus disease 2019 on contraception use in France
|
Roland, Noémie
|
|
|
78 |
5 |
p. 593-603
|
artikel
|
| 7 |
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
|
Jonville-Bera, Annie Pierre
|
|
|
78 |
5 |
p. 467-475
|
artikel
|
| 8 |
Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
|
Bihan, Kevin
|
|
|
78 |
5 |
p. 531-547
|
artikel
|
| 9 |
Pharmacoepidemiology and public decision
|
Zureik, Mahmoud
|
|
|
78 |
5 |
p. 549-551
|
artikel
|
| 10 |
Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
|
Jonville-Bera, Annie Pierre
|
|
|
78 |
5 |
p. 477-488
|
artikel
|
| 11 |
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
|
Grandvuillemin, Aurélie
|
|
|
78 |
5 |
p. 523-529
|
artikel
|
| 12 |
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
|
Valnet-Rabier, Marie-Blanche
|
|
|
78 |
5 |
p. 499-507
|
artikel
|
| 13 |
Potentially inappropriate medications and polypharmacy in the older population: A nationwide cross-sectional study in France in 2019
|
Drusch, Solène
|
|
|
78 |
5 |
p. 575-584
|
artikel
|
| 14 |
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
|
Salvo, Francesco
|
|
|
78 |
5 |
p. 509-515
|
artikel
|
| 15 |
Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview
|
Billioti de Gage, Sophie
|
|
|
78 |
5 |
p. 585-591
|
artikel
|
| 16 |
Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?
|
Pariente, Antoine
|
|
|
78 |
5 |
p. 565-573
|
artikel
|
Tijdschrift beschrijving